ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Circulating Inflammation Markers and Prospective Risk for Lung Cancer

Tuesday, December 17, 2013

Submitted by

Source

Source Name: Journal of the National Cancer Institute

Source URL: http://jnci.oxfordjournals.org/content/105/24/1871.abstract.html?etoc

Author(s)

MS Shiels, RM Pfeiffer, A Hildesheim, EA Engels, TJ Kemp, J-H Park, HA Katki, J Koshiol, G Shelton, NE Caporaso, LA Pinto, AK Chaturvedi

A case-control study within a large screening trial was performed to evaluate the relationship of serum inflammation markers and lung cancer. Of 68 evaluable markers, 11 were found to have a significant association with lung cancer. Increasing marker levels were associated with increasing cancer risk. The findings were unrelated to cell type and smoking status.